Clinical Trial Update: Effects of Nitric Oxide on the Endothelium During Hemolysis. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the effects of inhaled nitric oxide on the endothelium during intravascular hemolysis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Endothelial Dysfunction
• Intravascular Hemolysis

Drugs mentioned

• Nitric Oxide (nitric oxide)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Endothelial Dysfunction, Hemolysis Intravascular | Phase 2 | Status: WITHDRAWN